Physician profile
Michael Davis
NPI 1689928061
$5,950.08
in general payments reported to CMS, 2019-2025
14 companies · $22.60 in 2025
The $22.60 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $1,211 · 2021: $225 · 2022: $278 · 2023: $242 · 2024: $3,000 · 2025: $22.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,255 · Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,255.21 |
| Food and Beverage | $1,009.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,064.03 | 2019-2024 | Xact, Optis |
| Medtronic Vascular, INC. | $1,523.92 | 2019-2020 | |
| Medtronic, INC. | $612.19 | 2021-2025 | Endurant Iis, In.Pact Admiral, Hawkone |
| Silk Road Medical, INC. | $393.98 | 2019 | |
| Cardiovascular Systems INC. | $120.05 | 2020-2021 | |
| Inari Medical, INC. | $46.61 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $42.35 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.92 | 2023 | Lifevest |
| Philips North America LLC | $29.86 | 2022-2023 | |
| Bard Peripheral Vascular, INC. | $26.60 | 2022 | |
| Stimwave Technologies Incorporated | $15.41 | 2021 | |
| Merck Sharp & Dohme LLC | $14.97 | 2022 | |
| Tactile Systems Technology INC | $13.65 | 2022 | |
| Kci USA, INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.